|
|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2026
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/34718
| Title: | GASTROINTESTINAL DISORDERS IN RHEUMATIC DISEASES IN CHILDREN |
| Authors: | Lakshmi, Kuttiyakkil |
| Keywords: | pediatric rheumatic diseases;gastrointestinal disorders;juvenile idiopathic arthritis;drug -induced toxicity;multidisciplinary management |
| Issue Date: | 2026 |
| Publisher: | Centrul Editorial-Poligrafic Medicina |
| Citation: | Lakshmi, Kuttiyakkil. GASTROINTESTINAL DISORDERS IN RHEUMATIC DISEASES IN CHILDREN. In: MedEspera 2026, p. 904. ISBN 978-9975-82-486-6. |
| Abstract: | Introduction. Pediatric rheumatic diseases, encompassing juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE), juvenile dermatomyositis (JDM), and juvenile systemic sclerosis (JSSc), constitute chronic autoimmune disorders predominantly affecting the musculoskeletal system. Gastrointestinal (GI) involvement represents a critical extraarticular manifestation, characterised by dysphagia, gastroesophageal reflux disease (GERD), abdominal pain, diarrhoea, intestinal inflammation, and hepatic dysfunction. Pathogenesis involves autoimmune-mediated mucosal damage, vasculopathy, dysmotility, or iatrogenic effects from pharmacotherapies including nonsteroidal anti-inflammatory drugs (NSAIDS), glucocorticoids, methotrexate, and biologic agents such as tumour necrosis factor inhibitors. Unmitigated GI complications precipitate malnutrition, impaired statural growth, and diminished quality of life, necessitating systematic surveillance. Aim of study. This investigation systematically evaluates epidemiology, pathophysiological mechanisms, clinical spectrum, diagnostic modalities, and interdisciplinary management strategies for GI disorders in paediatric rheumatic diseases. Methods and materials. A comprehensive descriptive literature review was conducted across PubMed, Google Scholar, Scopus, and paediatric rheumatology repositories. Inclusion criteria comprised peer-reviewed articles, systematic reviews, case series, and clinical guidelines published from 2010 to 2025, specifically addressing GI manifestations in JIA, JSLE, JDM, and JSSc. Data synthesis focused on prevalence metrics, immunological pathways, endoscopic correlation, and therapeutic efficacy. Results. GI symptomatology manifests in up to 50% of JSSc and JDM cohorts, with predominant upper GI tract involvement (dysphagia, reflux); intestinal pseudo-obstruction complicates 20-30% of severe presentations. Hepatic transaminitis is associated with methotrexate-induced hepatotoxicity (15-25%) or autoimmune hepatitis in JSLE. Diagnostic precision is enhanced via endoscopy, gastrointestinal manometry, and serological profiling to declinate disease-from treatment-related aetiology. Conclusions. GI manifestations exert substantial influence on clinical trajectories in paediatric rheumatology; proactive monitoring and multidisciplinary collaboration - integrating rheumatologists, gastroenterologists and nutritionists- are imperative for optimising outcomes. Prospective longitudinal investigations are indicated to establish evidence - based protocols. |
| metadata.dc.relation.ispartof: | MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 |
| URI: | https://medespera.md/documents/abstract-book-4.pdf https://repository.usmf.md/handle/20.500.12710/34718 |
| ISBN: | 978-9975-82-486-6 |
| Appears in Collections: | MedEspera 2026
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|